Latest News

05.14.21

GenSight Biologics Provides 2021 Operations Update in the Context of COVID-19

Source: GenSight Biologics

05.14.21

Prevent Blindness Declares Second Annual Inherited Retinal Disease (IRD) Genetic Testing Week as May 16-22

Source: Prevent Blindness

05.14.21

Arctic Vision Announces Exclusive Licensing Agreement With ActualEyes

Source: Arctic Vision

05.14.21

ReGenTree Announces Additional Results From ARISE-3 Trial Using RGN-259 for the Treatment of Dry Eye

Source: ReGenTree

05.13.21

At-Home App Helps Patients Stay Engaged and Adherent to Vision Monitoring Remotely

Source: Novartis

05.13.21

New Study Identifies More People With Vision Loss and Blindness Than Previously Estimated

Source: Prevent Blindness

05.13.21

First Pediatric Patient with Rare Genetic Eye Disease Dosed in Clinical Trial

Source: ProQR Therapeutics

05.13.21

CDC Endorses Use of Pfizer, BioNTech COVID-19 Vaccine in Teens as Young as 12

Source: FirstWord

05.13.21

Gemini Therapeutics Completes Enrollment in Phase 2a Study of GEM103 as an Add-On to Anti-VEGF Therapy for the Treatment of Wet AMD

Source: Gemini Therapeutics

05.13.21

NUST MISIS Scientists Say They Developed a Safe Drug to Treat Eye Inflammation

Source: The National University of Science and Technology MISIS

05.12.21

Tilak Healthcare Launches US Pilot for OdySight Medical Vision Monitoring App

Source: Tilak Healthcare

05.12.21

Lumenis Named “Best Overall Medical Device Company” in 2021 MedTech Breakthrough Awards

Source: Lumenis

05.12.21

Euclid Systems Launches New Euclid MAX Ortho-K Lens

Source: Euclid Systems

05.12.21

Modernizing Medicine Releases Enhanced Ophthalmic Image Management to Improve Clinical Workflow

Source: Modernizing Medicine

05.12.21

Johnson & Johnson Vision Announces FDA Approval of Acuvue Abiliti Overnight Therapeutic Lenses for Myopia Management

Source: Johnson & Johnson Vision

05.12.21

Ocuphire Completes Enrollment in VEGA-1 Phase 2 Trial Investigating Nyxol in Combination with Low-Dose Pilocarpine for Treatment of Presbyopia

Source: Ocuphire

View more stories